|
Fear of Recurrence and Stopping Immunotherapy
RECRUITINGN/ASponsored by University of Pittsburgh
Actively Recruiting
PhaseN/A
SponsorUniversity of Pittsburgh
Started2021-08-02
Est. completion2027-12-31
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT04761328
Summary
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Eligibility
Age: 21 Years+Healthy volunteers accepted
Inclusion Criteria: * Age 21 years and older * Fluent in English * Diagnosis of cancer and history of treatment with immunotherapy Exclusion Criteria: * Active suicidal ideation, delusions or hallucinations
Conditions4
AnxietyCancerCognitive Behavioral TherapyDepression
Locations1 site
UPMC Hillman Cancer Centers
Pittsburgh, Pennsylvania, 15213
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Pittsburgh
Started2021-08-02
Est. completion2027-12-31
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT04761328